Company
Intellia Therapeutics ($NTLA)
Overview
Develops gene-editing medicines for serious diseases. Its clinical programmes use CRISPR delivered inside the body to treat inherited protein disorders and recurrent swelling.
Company
Develops gene-editing medicines for serious diseases. Its clinical programmes use CRISPR delivered inside the body to treat inherited protein disorders and recurrent swelling.